Press Releases

SOUTH SAN FRANCISCO, Calif., Jan. 26, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that it will report financial
January 26, 2023
Displaying 21 - 21 of 21
Print Page
RSS Feeds
Email Alerts
Contact IR